PERG adaptation for detection of retinal ganglion cell dysfunction in glaucoma: a pilot diagnostic accuracy study

被引:0
|
作者
T. Salgarello
G. M. Cozzupoli
A. Giudiceandrea
A. Fadda
G. Placidi
E. De Siena
F. Amore
S. Rizzo
B. Falsini
机构
[1] Fondazione Policlinico Universitario A. Gemelli IRCCS - Università Cattolica del Sacro Cuore,Institute of Ophthalmology
[2] Università Cattolica del Sacro Cuore,Institute of Ophthalmology
[3] Istituto Clinico Humanitas,Eye Center
[4] Istituto Superiore di Sanità,Department of Cardiovascular, Dysmetabolic and Aging
[5] Fondazione Policlinico Universitario A. Gemelli IRCCS,Associated Diseases
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
It has been previously demonstrated that the adaptive phase changes of steady-state pattern electroretinogram (SS-PERG), recorded during 4-min presentation of patterned stimuli, are reduced in glaucoma suspects and patients compared to normal subjects. Our study aims at testing the hypothesis that adaptive changes of SS-PERG, recorded using the novel optimized Next Generation PERG (PERGx) protocol, differ between glaucoma patients and controls. In this pilot cross-sectional study, we included 28 glaucoma patients and 17 age-matched normal subjects. Both patients and controls underwent a full ophthalmologic examination, visual field testing, OCT and PERGx. The PERGx signal was sampled over 2 min (providing 1 noise and 9 signal packets) in response to alternating gratings generated on an OLED display. PERGx amplitude and phase were analyzed to quantify adaptive changes over recording time. Receiver operating characteristic (ROC) curves were used to study the diagnostic accuracy of PERGx parameters in distinguishing glaucoma patients from normal subjects. PERGx amplitude and phase data showed declining trends in both groups. PERGx amplitude slope and grand-average vector amplitude and phase were significantly different in patients compared to controls (p < 0.01), whereas phase angular dispersion was greater in patients but not significantly different between the two groups. The area under the ROC curves were 0.87 and 0.76 for PERGx amplitude slope and grand-average vector amplitude, and 0.62 and 0.87 for PERGx angular dispersion and grand-average vector phase, respectively. The PERGx paradigm resulted highly accurate in detecting the reduction of amplitude adaptive changes in glaucoma patients, presumably due to the loss of functional retinal ganglion cell autoregulation. Thus, PERG adaptation, recorded by this new protocol, might be helpful in the identification and diagnosis of early glaucomatous dysfunction.
引用
收藏
相关论文
共 50 条
  • [31] The Role of Retinal Ganglion Cell Structure and Function in Glaucoma
    Feng, Kathy Ming
    Tsung, Ta-Hsin
    Chen, Yi-Hao
    Lu, Da-Wen
    CELLS, 2023, 12 (24)
  • [32] Mechanisms of Retinal Ganglion Cell Injury in Aging and Glaucoma
    Chrysostomou, Vicki
    Trounce, Ian A.
    Crowston, Jonathan G.
    OPHTHALMIC RESEARCH, 2010, 44 (03) : 173 - 178
  • [33] Estimating the Rate of Retinal Ganglion Cell Loss in Glaucoma
    Medeiros, Felipe A.
    Zangwill, Linda M.
    Anderson, Douglas R.
    Liebmann, Jeffrey M.
    Girkin, Christopher A.
    Harwerth, Ronald S.
    Fredette, Marie-Josee
    Weinreb, Robert N.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 154 (05) : 814 - 824
  • [34] Mouse models of retinal ganglion cell death and glaucoma
    McKinnon, Stuart J.
    Schlamp, Cassandra L.
    Nickells, Robert W.
    EXPERIMENTAL EYE RESEARCH, 2009, 88 (04) : 816 - 824
  • [35] Gene therapy for retinal ganglion cell neuroprotection in glaucoma
    A M Wilson
    A Di Polo
    Gene Therapy, 2012, 19 : 127 - 136
  • [36] Mechanisms of retinal ganglion cell injury and defense in glaucoma
    Qu, Juan
    Wang, Danyi
    Grosskreutz, Cynthia L.
    EXPERIMENTAL EYE RESEARCH, 2010, 91 (01) : 48 - 53
  • [37] Glial modulation of retinal ganglion cell death in glaucoma
    Tezel, G
    Wax, MB
    JOURNAL OF GLAUCOMA, 2003, 12 (01) : 63 - 68
  • [38] Retinal Ganglion Cell Death in Glaucoma: Advances and Caveats
    Yang, Yuting
    Sun, Xinghuai
    CURRENT EYE RESEARCH, 2023, 48 (01) : 1 - 10
  • [39] Gene therapy for retinal ganglion cell neuroprotection in glaucoma
    Wilson, A. M.
    Di Polo, A.
    GENE THERAPY, 2012, 19 (02) : 127 - 136
  • [40] Apoptotic cell death of retinal ganglion cells in glaucoma
    Vinjamaram, S
    Chalam, KV
    Gupta, S
    Shah, V
    MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 308A - 308A